lutetium has been researched along with phosphoramidon in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breeman, WA; de Blois, E; de Jong, M; Krenning, EP; Maina, T; Marsouvanidis, PJ; Melis, M; Nock, BA | 1 |
1 other study(ies) available for lutetium and phosphoramidon
Article | Year |
---|---|
In vivo enzyme inhibition improves the targeting of [177Lu]DOTA-GRP(13-27) in GRPR-positive tumors in mice.
Topics: Animals; Cell Line, Tumor; Gastrin-Releasing Peptide; Glycopeptides; Heterografts; Humans; Lutetium; Male; Mice; Mice, Nude; Neprilysin; Peptide Fragments; Prostatic Neoplasms; Protease Inhibitors; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution | 2014 |